Advertisement
Advertisement
Business /

Companies

Related Topics:
China’s private sector

China’s Jiangsu Aidea eyes Hong Kong IPO as gateway to US, European Aids markets

Yangzhou-based drug maker views Hong Kong as a ‘good window’ for its international expansion in HIV and Aids treatments.

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

Pinduoduo operator’s profit slides as firm cites higher reinvestment

Results reflect a pivotal year for PDD Holdings, as breakneck growth gives way to more stable pace.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW